QiShenYiQi Inhibits Tissue Plasminogen Activator–Induced Brain Edema and Hemorrhage after Ischemic Stroke in Mice

Background: Thrombolysis with tissue plasminogen activator (tPA) remains the only approved drug therapy for acute ischemic stroke. However, delayed tPA treatment is associated with an increased risk of brain hemorrhage. In this study, we assessed whether QiShenYiQi (QSYQ), a compound Chinese medicin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Yang Ye, Quan Li, Chun-Shui Pan, Li Yan, Kai Sun, Xiao-Yi Wang, Shu-Qi Yao, Jing-Yu Fan, Jing-Yan Han
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-01-01
coleção:	Frontiers in Pharmacology
Assuntos:	blood-brain barrier hemorrhage ischemic stroke QiShenYiQi tissue plasminogen activator
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2021.759027/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!